MM Oken

1.0k total citations
15 papers, 797 citations indexed

About

MM Oken is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, MM Oken has authored 15 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in MM Oken's work include Multiple Myeloma Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Myeloid Leukemia Research (4 papers). MM Oken is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Myeloid Leukemia Research (4 papers). MM Oken collaborates with scholars based in United States and Israel. MM Oken's co-authors include Brian Van Ness, Daniel D. Billadeau, NE Kay, Lois Quam, Patricia T. Greipp, RA Kyle, M J O'Connell, Traci Leong, Robert A. Kyle and PA Cassileth and has published in prestigious journals such as Blood, Leukemia and PubMed.

In The Last Decade

MM Oken

15 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MM Oken United States 12 587 349 246 146 106 15 797
Harousseau Jl France 12 607 1.0× 350 1.0× 301 1.2× 84 0.6× 73 0.7× 42 760
D Samson United Kingdom 14 549 0.9× 213 0.6× 196 0.8× 108 0.7× 54 0.5× 23 684
S. Wittebol Netherlands 10 387 0.7× 198 0.6× 272 1.1× 114 0.8× 107 1.0× 16 581
JU Gutterman United States 11 581 1.0× 152 0.4× 243 1.0× 337 2.3× 74 0.7× 23 876
J.P. Jouet France 6 492 0.8× 178 0.5× 142 0.6× 83 0.6× 120 1.1× 9 545
Sylvie Ramond France 13 402 0.7× 312 0.9× 274 1.1× 287 2.0× 140 1.3× 18 792
Kimberly J. Henderson United States 13 1.0k 1.8× 955 2.7× 531 2.2× 221 1.5× 73 0.7× 18 1.3k
GH Reaman United States 11 341 0.6× 251 0.7× 103 0.4× 89 0.6× 327 3.1× 17 635
H. J. Adriaansen Netherlands 12 256 0.4× 172 0.5× 120 0.5× 142 1.0× 172 1.6× 20 568
Clara Cesana Italy 15 439 0.7× 214 0.6× 139 0.6× 238 1.6× 27 0.3× 33 656

Countries citing papers authored by MM Oken

Since Specialization
Citations

This map shows the geographic impact of MM Oken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MM Oken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MM Oken more than expected).

Fields of papers citing papers by MM Oken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MM Oken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MM Oken. The network helps show where MM Oken may publish in the future.

Co-authorship network of co-authors of MM Oken

This figure shows the co-authorship network connecting the top 25 collaborators of MM Oken. A scholar is included among the top collaborators of MM Oken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MM Oken. MM Oken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Kim, Kyung‐Min, MM Oken, Louis Letendre, et al.. (2000). Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483). Leukemia. 14(8). 1349–1353. 25 indexed citations
3.
Oken, MM, et al.. (2000). Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Leukemia. 14(8). 1345–1348. 19 indexed citations
4.
Leong, Traci, Lois Quam, Daniel D. Billadeau, et al.. (1996). Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial. Blood. 88(7). 2699–2706. 173 indexed citations
5.
Winter, JN, Janet Andersen, Daina Variakojis, et al.. (1996). Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas. Blood. 88(10). 3919–3925. 15 indexed citations
6.
Kay, NE, MM Oken, RA Kyle, et al.. (1995). Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group [letter]. Blood. 86(10). 4000–4001. 13 indexed citations
7.
Murray, David M., et al.. (1995). The Minnesota Cancer Pain Project: design, methods, and education strategies.. PubMed. 10(2). 102–12. 24 indexed citations
8.
Billadeau, Daniel D., Lois Quam, Wendy Thomas, et al.. (1992). Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood. 80(7). 1818–1824. 7 indexed citations
9.
Billadeau, Daniel D., Lois Quam, NE Kay, et al.. (1992). Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood. 80(7). 1818–1824. 148 indexed citations
10.
Cassileth, PA, Elizabeth Lynch, MM Oken, et al.. (1992). Varying intensity of postremission therapy in acute myeloid leukemia. Blood. 79(8). 1924–1930. 163 indexed citations
11.
12.
Billadeau, Daniel D., Patricia T. Greipp, RA Kyle, et al.. (1991). Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease. Blood. 78(11). 3021–3029. 120 indexed citations
13.
14.
Yunis, Juan J., et al.. (1986). Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood. 67(6). 1721–1730. 7 indexed citations
15.
Oken, MM, et al.. (1981). Pharmacokinetics of bleomycin after im administration in man.. PubMed. 65(5-6). 485–9. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harousseau Jl Breakdown of academic impact, for papers by D Samson Breakdown of academic impact, for papers by S. Wittebol Breakdown of academic impact, for papers by JU Gutterman Breakdown of academic impact, for papers by J.P. Jouet Breakdown of academic impact, for papers by Sylvie Ramond Breakdown of academic impact, for papers by Kimberly J. Henderson Breakdown of academic impact, for papers by GH Reaman Breakdown of academic impact, for papers by H. J. Adriaansen Breakdown of academic impact, for papers by Clara Cesana
Rankless by CCL
2026